Furthermore, the aberrant expression of <i>CD34</i>, <i>PPARG</i>, and <i>PTEN</i> provides mechanistic insights into the vascular remodeling and fragility underlying AML hemorrhage, suggesting potential targets for future therapeutic research. Here, CD34 is linked to acute myeloid leukemia.